Search details
1.
Genetic counseling for congenital heart disease - Practice resource of the National Society of Genetic Counselors.
J Genet Couns
; 31(1): 9-33, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34510635
2.
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).
Oncologist
; 25(6): 523-531, 2020 06.
Article
in English
| MEDLINE | ID: mdl-31872928
3.
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.
Gastroenterology
; 143(4): 917-26.e1, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22796132
4.
Impact of disease progression date determination on progression-free survival estimates in advanced lung cancer.
Cancer
; 118(21): 5358-65, 2012 Nov 01.
Article
in English
| MEDLINE | ID: mdl-22434489
5.
Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma.
Gynecol Oncol
; 122(1): 116-20, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-21514634
6.
Newborn and carrier screening for spinal muscular atrophy.
Am J Med Genet A
; 152A(7): 1608-16, 2010 Jul.
Article
in English
| MEDLINE | ID: mdl-20578137
7.
A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.
Cancer Prev Res (Phila)
; 9(12): 906-914, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27658890
8.
Population pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjects.
J Clin Pharmacol
; 53(4): 403-12, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23436338
9.
Randomized phase II trial of sulindac for lung cancer chemoprevention.
Lung Cancer
; 79(3): 254-61, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-23261228
10.
Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.
J Thorac Oncol
; 7(5): 919-22, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22722792
11.
Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668.
Cancer Prev Res (Phila)
; 4(3): 347-53, 2011 Mar.
Article
in English
| MEDLINE | ID: mdl-21372034
12.
Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention.
Cancer Prev Res (Phila)
; 4(2): 259-69, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21209397
13.
Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study.
J Thorac Oncol
; 5(9): 1346-53, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20651609
14.
Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.
J Clin Oncol
; 28(4): 614-9, 2010 Feb 01.
Article
in English
| MEDLINE | ID: mdl-19841321
15.
Endpoints in phase II trials for advanced non-small cell lung cancer.
J Thorac Oncol
; 5(1): 3-9, 2010 Jan.
Article
in English
| MEDLINE | ID: mdl-19884856
16.
Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222.
Cancer Manag Res
; 1: 61-8, 2009 Jun 17.
Article
in English
| MEDLINE | ID: mdl-21188124
17.
Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study.
J Thorac Oncol
; 4(4): 479-85, 2009 Apr.
Article
in English
| MEDLINE | ID: mdl-19347979
Results
1 -
17
de 17
1
Next >
>>